banner
TMO image

Thermo Fisher Scientific Inc.

TMO

NYSE

572.5

USD
+0.59(+0.10%)

As of today

Thermo Fisher Scientific Inc. fundamentals

Key ratios

P/E Ratio
33
Price/Book
4.24
Debt/Equity
69.93%
Return on Equity
13.11%
Dividend Yield
0.29%
EBITDA
11.80B

Statements Highlights

Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Total Revenue32,218,000,00039,211,000,00044,915,000,00042,857,000,00042,879,000,000
Gross Profit16,027,000,00019,634,000,00019,011,000,00017,194,000,00017,728,000,000
Operating Income7,897,000,00010,318,000,0008,525,000,0007,446,000,0007,662,000,000
Net Income6,375,000,0007,725,000,0006,950,000,0005,995,000,0006,335,000,000
Total Assets69,052,000,00095,123,000,00097,154,000,00098,726,000,00097,321,000,000
Total Current Liabilities10,304,000,00013,436,000,00017,010,000,00014,012,000,00013,332,000,000
Total Equity34,517,000,00040,977,000,00044,148,000,00046,842,000,00049,671,000,000
Free Cash Flow6,815,000,0007,020,000,0006,911,000,0006,927,000,0007,267,000,000
Cash from Operations8,289,000,0009,543,000,0009,154,000,0008,406,000,0008,667,000,000
Cash from Investing-1,510,000,000-21,932,000,000-2,159,000,000-5,142,000,000-5,841,000,000
Cash from Financing959,000,0006,581,000,000-2,810,000,000-3,622,000,000-6,792,000,000
Net Change in Cash7,914,000,000-5,845,000,0004,046,000,000-440,000,000-4,057,000,000

Dividends

Analyst Recomendations